Effects of Interrupting Sedentary Time on Glycemic Control in Older Overweight and Obese Adults

Diabetes Clinical Trial

— B-WELL  

Official title:

Effects of Interrupting Sedentary Time on Glycemic Control in Older Overweight and Obese Adults

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01997021
• Other study ID #: 13-2594
• Status: Completed
• Phase: N/A
• Start date: November 2013
• Est. completion date: December 31, 2014

Study information

• Verified date: August 2021
• Source: University of Colorado, Denver
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Increasing physical activity in older adults has important implications for treating obesity related metabolic conditions, however the interaction of aging- and obesity-related declines in physical function may make adding structured exercise particularly challenging for this group. Given these challenges, an alternative prescription to traditional structured exercise, may be short bouts of intermittent walking scattered throughout the day - this may be an effective strategy to increase physical activity, reduce sedentary behavior, and improve glycemic control in overweight/obese older adults. The purpose of this project is to determine how interrupting sedentary time with short bouts of moderate intensity walking affects important metabolic outcomes in older, overweight adults. It would also be of interest to compare the effects of short, frequent interruptions in sedentary behavior to a traditional exercise prescription (continuous 30 min walking bout) on metabolic outcomes (e.g., glycemic control, insulin sensitivity, and 24 h fat oxidation). Thus, the overall aims of the proposed research are to 1) Determine the effect of performing short bouts of moderate-intensity intermittent walking (IW) on glucose and insulin metabolism compared to uninterrupted sitting (US) in older overweight and obese adults. 2) To compare the effects of interrupting sedentary time (IW) vs. a traditional exercise prescription (continuous 30 m walk (CW)) on metabolism.

The investigators hypothesize that interrupting sedentary time with intermittent walking will improve glucose and insulin metabolism compared to uninterrupted sitting and it will be as effective at improving metabolism as a single continuous 30 min walk.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 25
• Est. completion date: December 31, 2014
• Est. primary completion date: December 31, 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 60 Years to 85 Years

Eligibility

Inclusion Criteria:

• Aged 60-85 yr • BMI 25-35 kg.m-2

• Non-exercisers (<150 m/wk of moderate intensity exercise)

• Sedentary (>60% of waking day sedentary)

• Able to walk on a treadmill for 36 continuous minutes at a pace of at least 2.0 mph

Exclusion Criteria:

• Self-reported acute or chronic disease (e.g. diabetes, heart disease, thyroid disease)

• Fasting plasma glucose = 126 mg/dl - participants will not be excluded if they an abnormal post prandial glucose levels (e.g. glucose = 200 mg/dl) following the MTT's.

• Tobacco use (cigarettes, cigars, or chewing tobacco) within the past 6 months

• Females who previously used (> 6 months) or are currently using any formulation of estrogen-based hormone therapy (e.g., oral Premarin, transdermal 17-estradiol, selective estrogen receptor modulators).

• Resting diastolic blood pressure > 100 mm mercury or resting systolic blood pressure > 160 mm mercury

• Contra-indications to exercise (e.g. orthopedic limitations)

• Unable to walk on a treadmill for 36 continuous minutes at a pace of at least 2.0 mph

Related Conditions & MeSH terms

• Aging
• Diabetes
• Metabolic Syndrome
• Overweight

Intervention

Other:
• US
US is a 5-hour intervention/condition where participants will be required to sit quietly for 5 consecutive hours.
• IW
IW is a 24-hour intervention/condition where participants interrupt sedentary time with short 1.5 minute walking bout.
• CW
CW is a 24-hour intervention/condition where participants perform a 36 minute continuous walking bout and are seated the remainder of the time.

Locations

Country	Name	City	State
United States	University of Colorado Denver Anschutz Medical Campus	Aurora	Colorado

Sponsors (1)

Lead Sponsor	Collaborator
University of Colorado, Denver

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Incremental area under the glucose curve in response to meal tolerance test (MTT)	Meal tolerance test is performed during uninterrupted sitting condition and during intermittent walking condition. Glucose area under the curve (AUC) is compared between conditions.	Hourly for 5 hours after meal is consumed
Primary	Area under the insulin curve in response to meal tolerance test	Meal tolerance test is performed during uninterrupted sitting condition and during intermittent walking condition. Insulin AUC is compared between conditions.	Hourly for 5 hours after meal is consumed
Secondary	Postprandial glycemia in response to meal tolerance test	Postprandial glycemia (PPG) will be measured using a continuous glucose monitor. Peak PPG, rate of change in peak PPG and duration of hyperglycemia will be calculated. Meal tolerance test will be performed during uninterrupted sitting condition and during intermittent walking condition. PPG will be compared between conditions.	Continuously for 5 hours after meal is consumed
Secondary	Insulin sensitivity	Insulin sensitivity will be measured using a hyperinsulinemic euglycemic clamp. IS will be assessed after intermittent walking condition and after continuous walk condition. IS will be compared between conditions.	Immediately post 24 hr intermittent walking and continuous walking conditions
Secondary	24-hr Fat Oxidation	Fat oxidation will be measured in a whole room indirect calorimeter during the intermittent walking condition and during the continuous walk condition. Fat oxidation will be compared between conditions.	Continuously during 24 hr intermittent walking and continuous walking conditions
Secondary	24-hour Glycemic variability	Glycemic variability will be measured using a continuous glucose monitor during the intermittent walking condition and during the continuous walk condition. Glycemic variability will be compared between conditions.	Continuously during 24 hr intermittent walking and continuous walking conditions